Back to the main directory
Company Analysis / Equity
- Ceasing Coverage on Briscoe Group Australasia Limited by Morningstar
- AmeriGas' strong balance sheet supports distributions despite warm 2016 and 2017. by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- Caterpillar's scale creates a wide moat, but new competition threatens its industry leadership. by Morningstar
- Darden Momentum Continues Despite Soft Industry Conditions, Full-Year Outlook Still Achievable by Morningstar
- F5 continues to lead the ADC market while seeking to meaningfully expand its portfolio. by Morningstar
- Tighter capacity should rekindle contract pricing for Heartland and its peers in 2018. by Morningstar
- Restructuring and reorganization efforts have sharpened Jacobs' focus and bolstered efficiency. by Morningstar
- Legg Mason's Flows Remain Positive in 1Q; No Change to $38 per Share FVE by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- NetEase Faces Near-Term Slowdown in Online Games, but We Are Confident About Long-Term Growth by Morningstar
- Despite insulin pricing pressure, Sanofi's focus on steady business lines drives long-term growth. by Morningstar
- Skyworks Gives a Solid Second-Half Outlook as Business Conditions Appear Steady; Maintain $98 FVE by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- TJX’s Top-Line Growth Muted in 3Q but Likely Only Short Term; Shares Undervalued by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- KBR emphasizes government services and energy innovations while deemphasizing a controversial past. by Morningstar
- Initiation of Narrow-Moat Yutong with Stable Trend, and FVE of CNY 24.5 per Share by Morningstar
- Continued growth in FTSE Russell and OTC clearing should propel LSE forward. by Morningstar
- Spectra Partners' Impressive Earnings and Distribution Growth Should Continue by Morningstar
- CRP’s Profit Warning Shows Slight Miss, but No Change in Stable Dividend by Morningstar
- Charter Halls Moves into Bigger Malls with Purchase of Salamander Bay. AUD 4.00 FVE Unchanged by Morningstar
- Lower credit costs and expenses are key to improved profitability for Danske Bank. by Morningstar
- Disposal of 9 Rigs a Positive to Sembcorp Marine’s Balance Sheet; Long-Term Outlook Unchanged by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- Denbury Guidance for 2017 Up 1 Mboe/d at Midpoint Despite Budget Decrease by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- Illumina possesses a strong growth outlook, but disruptive competition remains longer-term threat. by Morningstar
- Defense budget growth and improved performance at L-3 will drive margin expansion. by Morningstar
- Marvell Continues to Exhibit Stabilization in its Core Segments; But Long-Term Growth Won't Be Easy by Morningstar
- NVR's capital efficiency is best-in-class among public homebuilders. by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- Simon's portfolio and stewardship position it well to compete in a new, uncertain retail world. by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- Tenet Healthcare Previews 3Q Adjusted Admission Weakness by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- Ceasing Coverage on Tower by Morningstar
- No Changes to Our View Following RB's First-Half Update; Shares Fully Priced by Morningstar
- DOL Fiduciary Rule Reportedly Delayed, but Industry Itself Is on Path to More Fiduciary Practices by Morningstar
- S/4HANA Adoption Continues in SAP’s In-Line Second Quarter; Modestly Raising FVEs by Morningstar
- Capgemini Provides 3Q Sales Update; North America Acceleration Encouraging; Shares at Premium by Morningstar
- Southern Cross Media Still Suffering Breakfast Indigestion by Morningstar
- Darzalex Shows Strong Efficacy in 1L Multiple Myeloma; Genmab's FVE Already Assumes Positive Results by Morningstar
- While its ROE target is optimistic, SEB has a stable business model with stellar asset quality. by Morningstar